Website
VCID: 139706
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers.Funding
Funding rounds
(1 Aug 2010)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Clarus Ventures II | Venture capital fund investing in biopharmaceuticals and medical technology | United States |
(1 Aug 2010)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States | |
|
Quaker BioVentures Inc | United States | ||
|
The Vertical Group Inc | United States |
(1 Jun 2006)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States |
(1 Jun 2006)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Latterell Venture Partners | United States | ||
|
PA Early Stage Partners | United States | ||
|
|
The Vertical Group Inc | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
Amgen Inc |
+1 (805) 447-1000 |
N/A |
|
|
Clarus Ventures II Venture capital fund investing in biopharmaceuticals and medical technology |
Series C | |
|
Hatteras Venture Partners III |
+1 (919) 484-0730 |
Series C |
|
|
Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
+1 (617) 252-4343 |
Series B Series C |
|
|
Latterell Venture Partners |
+1 (415) 399-9880 |
Series B Series C |
|
|
Nextech Invest Ltd |
+41 (1) 366-6611 |
Series C |
|
Novitas Capital |
Series C | |
|
|
PA Early Stage Partners |
Series B | |
|
Pfizer Inc |
+1 (212) 733-7034 |
Series C |
|
|
Quaker BioVentures Inc |
+1 (215) 988-6800 |
Series B Series C |
|
|
The Vertical Group Inc |
+1 (650) 566-9060 |
Series B Series C |